cytokines

Sketch of lungs

Innovent links IL-2 fusion protein to responses in small study

Innovent's bispecific immuno-oncology candidate IBI363 has been linked to a 100% response rate in a small cohort of Chinese lung cancer patients.

Nick Paul Taylor Jun 14, 2024 10:00am

An artists rendering of cytokines being released from immune cells

AACR: Mural debuts data for potential pipeline additions

Apr 10, 2024 11:16am

crowd leader differentiate follow

Gilead pays $43.5M for Xilio's early-phase IL-12 prospect

Mar 28, 2024 8:08am

graphic art of a right hand signing something

Sanofi pays $40M to join preclinical push against vexing target

Jan 29, 2024 8:00am

Red blood cells

Oncternal reports patient death in CAR-T dose-escalation study

Dec 28, 2023 10:52am

reshuffle pipeline target reorganize shift change

Equillium swaps subcutaneous cytokine inhibitor for oral option

Dec 21, 2023 10:58am